Retroject

Retroject is a biotechnology and medical device company focused on developing a novel delivery platform for advanced ocular therapies. The company's core technology is a specialized micro-injection system designed to deliver gene and cell therapies to the suprachoroidal and subretinal spaces of the eye with high precision. By enabling minimally invasive access to these critical layers, Retroject aims to improve the safety and efficacy of treatments for blinding diseases such as age-related macular degeneration and diabetic retinopathy. The platform is designed to be compatible with various therapeutic modalities, offering a standardized approach for pharmaceutical partners to administer complex biologics. Retroject's mission is to transform the standard of care for retinal disorders through superior delivery science.